TrialClinical and molecular hepatology2025

Switching to besifovir in patients with chronic hepatitis B receiving tenofovir disoproxil fumarate: A randomized trial.

Hyung Joon Yim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.